

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sister chromatid cohesion (GO:0007063) | 7.78061686 |
| 2 | auditory behavior (GO:0031223) | 6.02294215 |
| 3 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.99374834 |
| 4 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.57432058 |
| 5 | startle response (GO:0001964) | 4.33766198 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.20044517 |
| 7 | response to peptidoglycan (GO:0032494) | 4.20041697 |
| 8 | regulation of podosome assembly (GO:0071801) | 4.15291972 |
| 9 | cellular response to vitamin D (GO:0071305) | 4.01240740 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00518092 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.00518092 |
| 12 | low-density lipoprotein particle clearance (GO:0034383) | 3.97454617 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 3.69986796 |
| 14 | detection of other organism (GO:0098543) | 3.68396913 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.61344032 |
| 16 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.58864267 |
| 17 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.53729250 |
| 18 | mechanosensory behavior (GO:0007638) | 3.51669422 |
| 19 | protein localization to endosome (GO:0036010) | 3.46928037 |
| 20 | detection of bacterium (GO:0016045) | 3.46810606 |
| 21 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.42894602 |
| 22 | innervation (GO:0060384) | 3.37594256 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.35800416 |
| 24 | endothelial tube morphogenesis (GO:0061154) | 3.34331082 |
| 25 | morphogenesis of an endothelium (GO:0003159) | 3.34331082 |
| 26 | cellular response to prostaglandin stimulus (GO:0071379) | 3.33611361 |
| 27 | cellular response to vitamin (GO:0071295) | 3.27801194 |
| 28 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.24212879 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.24200575 |
| 30 | glycine metabolic process (GO:0006544) | 3.23740225 |
| 31 | regulation of mast cell degranulation (GO:0043304) | 3.23588192 |
| 32 | heparin biosynthetic process (GO:0030210) | 3.23253371 |
| 33 | heparin metabolic process (GO:0030202) | 3.23253371 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.18251892 |
| 35 | detection of molecule of bacterial origin (GO:0032490) | 3.18010255 |
| 36 | regulation of leukocyte degranulation (GO:0043300) | 3.17853881 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.15195865 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14173902 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14173902 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.14173902 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14173902 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.14173902 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14173902 |
| 44 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.13464672 |
| 45 | germinal center formation (GO:0002467) | 3.10594728 |
| 46 | response to auditory stimulus (GO:0010996) | 3.10244897 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09032536 |
| 48 | response to host (GO:0075136) | 3.08886325 |
| 49 | response to host defenses (GO:0052200) | 3.08886325 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08886325 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08433898 |
| 52 | response to host immune response (GO:0052572) | 3.08433898 |
| 53 | serine family amino acid catabolic process (GO:0009071) | 3.06805901 |
| 54 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06137615 |
| 55 | lung-associated mesenchyme development (GO:0060484) | 3.05133743 |
| 56 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.04870454 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04863194 |
| 58 | lysine metabolic process (GO:0006553) | 3.02973358 |
| 59 | lysine catabolic process (GO:0006554) | 3.02973358 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02296281 |
| 61 | protein kinase C signaling (GO:0070528) | 3.00792917 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 2.99659532 |
| 63 | barbed-end actin filament capping (GO:0051016) | 2.99513628 |
| 64 | cysteine metabolic process (GO:0006534) | 2.98835541 |
| 65 | positive regulation of monooxygenase activity (GO:0032770) | 2.98052406 |
| 66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97590687 |
| 67 | fructose metabolic process (GO:0006000) | 2.96913445 |
| 68 | histone H2A monoubiquitination (GO:0035518) | 2.95991034 |
| 69 | 2-oxoglutarate metabolic process (GO:0006103) | 2.95822309 |
| 70 | macroautophagy (GO:0016236) | 2.93880467 |
| 71 | folic acid transport (GO:0015884) | 2.93767961 |
| 72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.92298743 |
| 73 | cellular extravasation (GO:0045123) | 2.91292135 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91139273 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.89185568 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88367076 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.88286951 |
| 78 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.87535564 |
| 79 | midgut development (GO:0007494) | 2.86996217 |
| 80 | granulocyte activation (GO:0036230) | 2.83706965 |
| 81 | urea cycle (GO:0000050) | 2.82481010 |
| 82 | urea metabolic process (GO:0019627) | 2.82481010 |
| 83 | detection of biotic stimulus (GO:0009595) | 2.82177941 |
| 84 | genitalia morphogenesis (GO:0035112) | 2.82142012 |
| 85 | gland morphogenesis (GO:0022612) | 2.81300296 |
| 86 | negative regulation of cell fate specification (GO:0009996) | 2.81072856 |
| 87 | G-protein coupled receptor internalization (GO:0002031) | 2.77926964 |
| 88 | regulation of cardioblast differentiation (GO:0051890) | 2.77661020 |
| 89 | nuclear pore complex assembly (GO:0051292) | 2.77565184 |
| 90 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.77151989 |
| 91 | stress fiber assembly (GO:0043149) | 2.76975972 |
| 92 | NIK/NF-kappaB signaling (GO:0038061) | 2.76150804 |
| 93 | amino-acid betaine metabolic process (GO:0006577) | 2.76012183 |
| 94 | nephron tubule formation (GO:0072079) | 2.74825013 |
| 95 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.74451479 |
| 96 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.73869387 |
| 97 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.73097100 |
| 98 | neutrophil activation (GO:0042119) | 2.72748927 |
| 99 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72253320 |
| 100 | leukocyte aggregation (GO:0070486) | 2.72024690 |
| 101 | modulation by symbiont of host cellular process (GO:0044068) | 2.71825485 |
| 102 | positive regulation of organelle assembly (GO:1902117) | 2.70766307 |
| 103 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.70088989 |
| 104 | protein carboxylation (GO:0018214) | 2.70088989 |
| 105 | nuclear pore organization (GO:0006999) | 2.70005744 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 2.69114800 |
| 107 | response to laminar fluid shear stress (GO:0034616) | 2.68592360 |
| 108 | regulation of necroptotic process (GO:0060544) | 2.68339427 |
| 109 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.67997236 |
| 110 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.67458300 |
| 111 | hypotonic response (GO:0006971) | 2.66515638 |
| 112 | regulation of regulated secretory pathway (GO:1903305) | 2.65944536 |
| 113 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.65863593 |
| 114 | pore complex assembly (GO:0046931) | 2.65760217 |
| 115 | negative regulation of type 2 immune response (GO:0002829) | 2.64955669 |
| 116 | macrophage activation (GO:0042116) | 2.64505677 |
| 117 | DNA double-strand break processing (GO:0000729) | 2.64417961 |
| 118 | ruffle organization (GO:0031529) | 2.63284950 |
| 119 | morphogenesis of an epithelial fold (GO:0060571) | 2.63192828 |
| 120 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.61703032 |
| 121 | cellular response to nutrient (GO:0031670) | 2.61260863 |
| 122 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.60512809 |
| 123 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58986604 |
| 124 | serine family amino acid metabolic process (GO:0009069) | 2.58619694 |
| 125 | endothelial cell morphogenesis (GO:0001886) | 2.58171097 |
| 126 | negative regulation of necroptotic process (GO:0060546) | 2.57124550 |
| 127 | regulation of macrophage cytokine production (GO:0010935) | 2.56163230 |
| 128 | pinocytosis (GO:0006907) | 2.55952803 |
| 129 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.55741382 |
| 130 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54929299 |
| 131 | alpha-linolenic acid metabolic process (GO:0036109) | 2.54508002 |
| 132 | regulation of necrotic cell death (GO:0010939) | 2.54429478 |
| 133 | neutrophil mediated immunity (GO:0002446) | 2.54209127 |
| 134 | regulation of chromosome segregation (GO:0051983) | 2.53872116 |
| 135 | positive regulation of leukocyte degranulation (GO:0043302) | 2.53204680 |
| 136 | regulation of cholesterol storage (GO:0010885) | 2.52461210 |
| 137 | DNA-dependent DNA replication (GO:0006261) | 2.52210910 |
| 138 | negative regulation of interleukin-17 production (GO:0032700) | 2.51948637 |
| 139 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.51904955 |
| 140 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.51699871 |
| 141 | histone H2A ubiquitination (GO:0033522) | 2.50644628 |
| 142 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.49074163 |
| 143 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.49023714 |
| 144 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.48910342 |
| 145 | negative regulation of fibrinolysis (GO:0051918) | 2.48564436 |
| 146 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.48514021 |
| 147 | dorsal/ventral axis specification (GO:0009950) | 2.47589424 |
| 148 | regulation of cilium movement (GO:0003352) | 2.47568408 |
| 149 | interferon-gamma secretion (GO:0072643) | 2.47480567 |
| 150 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.47015303 |
| 151 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.45815787 |
| 152 | pyrimidine dimer repair (GO:0006290) | 2.45529700 |
| 153 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.45506304 |
| 154 | hemoglobin metabolic process (GO:0020027) | 2.45117168 |
| 155 | cellular response to arsenic-containing substance (GO:0071243) | 2.44859615 |
| 156 | response to arsenic-containing substance (GO:0046685) | 2.44734909 |
| 157 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.44614186 |
| 158 | plasma lipoprotein particle assembly (GO:0034377) | 2.44286586 |
| 159 | erythrocyte development (GO:0048821) | 2.42829645 |
| 160 | regulation of type 2 immune response (GO:0002828) | 2.39946742 |
| 161 | positive regulation of lipid catabolic process (GO:0050996) | 2.39260511 |
| 162 | nitrogen cycle metabolic process (GO:0071941) | 2.39239985 |
| 163 | protein-lipid complex assembly (GO:0065005) | 2.39175034 |
| 164 | regulation of early endosome to late endosome transport (GO:2000641) | 2.37821980 |
| 165 | regulation of protein polyubiquitination (GO:1902914) | 2.37615010 |
| 166 | embryonic foregut morphogenesis (GO:0048617) | 2.37532329 |
| 167 | myeloid cell activation involved in immune response (GO:0002275) | 2.37378460 |
| 168 | modulation by virus of host process (GO:0019054) | 2.36476229 |
| 169 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.35614113 |
| 170 | regulation of platelet aggregation (GO:0090330) | 2.34698757 |
| 171 | positive regulation of macrophage cytokine production (GO:0060907) | 2.33485590 |
| 172 | embryonic process involved in female pregnancy (GO:0060136) | 2.32980862 |
| 173 | immunoglobulin mediated immune response (GO:0016064) | 2.32133600 |
| 174 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.29996994 |
| 175 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.27844371 |
| 176 | positive regulation of mast cell activation (GO:0033005) | 2.27600704 |
| 177 | response to thyroid hormone (GO:0097066) | 2.26620158 |
| 178 | microglial cell activation (GO:0001774) | 2.25172031 |
| 179 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.24862197 |
| 180 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.22845835 |
| 181 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.22241266 |
| 182 | I-kappaB phosphorylation (GO:0007252) | 2.21441734 |
| 183 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.21193842 |
| 184 | myeloid cell development (GO:0061515) | 2.20213768 |
| 185 | type I interferon signaling pathway (GO:0060337) | 2.20103689 |
| 186 | cellular response to type I interferon (GO:0071357) | 2.20103689 |
| 187 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.19758794 |
| 188 | positive regulation of type 2 immune response (GO:0002830) | 2.19153053 |
| 189 | negative regulation of innate immune response (GO:0045824) | 2.17909378 |
| 190 | regulation of defense response to virus by virus (GO:0050690) | 2.17899583 |
| 191 | cellular response to virus (GO:0098586) | 2.17760204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.37684227 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.22820319 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.98743343 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.84623199 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53193803 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.22578170 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.21532012 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75500289 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74282502 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48919741 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45025585 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.41936247 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36053613 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.33869643 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31606767 |
| 16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.20864251 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.16561554 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15823737 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.14696428 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09974533 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07674817 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.06852249 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02715121 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98860208 |
| 25 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96751328 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.91492565 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87042851 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.84146122 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81208403 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.78257979 |
| 31 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76289994 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.76164805 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68527566 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.64251654 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64213272 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62749792 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62294552 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61565369 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58430082 |
| 40 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57417157 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57404001 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.57362811 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56812740 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55162717 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54588693 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53637701 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.52317889 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50106272 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.47158867 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47154972 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45374167 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42111428 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42080236 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41138388 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38777735 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38491821 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36419459 |
| 58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34300531 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33710762 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33235050 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31606181 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30587823 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30075212 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27846857 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27195175 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26701867 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25357726 |
| 68 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.25216315 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24647840 |
| 70 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23511521 |
| 71 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22685913 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22081504 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21473013 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20253267 |
| 75 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19371704 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19004845 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18936554 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17724729 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17251837 |
| 80 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16806476 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16688185 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.16615452 |
| 83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16238595 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16175945 |
| 85 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15983257 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15814600 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15245783 |
| 88 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14867162 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14848181 |
| 90 | MYC_22102868_ChIP-Seq_BL_Human | 1.13520647 |
| 91 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13281608 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13097137 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12542284 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12031733 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11087888 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10769746 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10756810 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10567257 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10321486 |
| 100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09621172 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09516133 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09516133 |
| 103 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09406548 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08280920 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08226152 |
| 106 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08155915 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07458168 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07261606 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06602445 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06542714 |
| 111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05404023 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05360708 |
| 113 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05275208 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04588209 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03678515 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03655888 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03301796 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02481282 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01893298 |
| 120 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01615321 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01123661 |
| 122 | MYB_26560356_Chip-Seq_TH2_Human | 1.00969798 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00584749 |
| 124 | MYB_26560356_Chip-Seq_TH1_Human | 0.99444878 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99270105 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99158698 |
| 127 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97441579 |
| 128 | P68_20966046_ChIP-Seq_HELA_Human | 0.97332228 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96281545 |
| 130 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.96164335 |
| 131 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94751760 |
| 132 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93604674 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93470901 |
| 134 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93227641 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92590100 |
| 136 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91337545 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90324916 |
| 138 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90302910 |
| 139 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89679753 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.89638747 |
| 141 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89302559 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88507536 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88282155 |
| 144 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87935030 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87261777 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86468444 |
| 147 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86201914 |
| 148 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85870854 |
| 149 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85513632 |
| 150 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85310729 |
| 151 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.85197711 |
| 152 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84762366 |
| 153 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84047636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.70515650 |
| 2 | MP0005248_abnormal_Harderian_gland | 3.36940371 |
| 3 | MP0003724_increased_susceptibility_to | 3.26013392 |
| 4 | MP0009840_abnormal_foam_cell | 3.15646215 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.11043603 |
| 6 | MP0003303_peritoneal_inflammation | 3.10769545 |
| 7 | MP0006054_spinal_hemorrhage | 3.03906711 |
| 8 | MP0005360_urolithiasis | 2.83918623 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.60490394 |
| 10 | MP0004130_abnormal_muscle_cell | 2.59328839 |
| 11 | MP0003436_decreased_susceptibility_to | 2.47020043 |
| 12 | MP0008961_abnormal_basal_metabolism | 2.40776214 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.26147803 |
| 14 | MP0005365_abnormal_bile_salt | 2.11554174 |
| 15 | MP0003828_pulmonary_edema | 2.09391010 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.00811469 |
| 17 | MP0005076_abnormal_cell_differentiation | 2.00032206 |
| 18 | MP0004510_myositis | 1.97135179 |
| 19 | MP0010307_abnormal_tumor_latency | 1.95655661 |
| 20 | MP0003075_altered_response_to | 1.90866287 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.86779660 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.84697210 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.75786001 |
| 24 | MP0005257_abnormal_intraocular_pressure | 1.75303864 |
| 25 | MP0000537_abnormal_urethra_morphology | 1.74986896 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.74633719 |
| 27 | MP0000685_abnormal_immune_system | 1.66299679 |
| 28 | MP0008004_abnormal_stomach_pH | 1.64015429 |
| 29 | MP0001790_abnormal_immune_system | 1.61199282 |
| 30 | MP0005387_immune_system_phenotype | 1.61199282 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.60672301 |
| 32 | MP0002723_abnormal_immune_serum | 1.57489643 |
| 33 | MP0009278_abnormal_bone_marrow | 1.57110804 |
| 34 | MP0005409_darkened_coat_color | 1.53034749 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.52977161 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51985075 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.49664396 |
| 38 | MP0001915_intracranial_hemorrhage | 1.48381026 |
| 39 | MP0001819_abnormal_immune_cell | 1.48007119 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.47872227 |
| 41 | MP0005083_abnormal_biliary_tract | 1.46399264 |
| 42 | MP0001800_abnormal_humoral_immune | 1.46270044 |
| 43 | MP0003329_amyloid_beta_deposits | 1.44929118 |
| 44 | MP0003111_abnormal_nucleus_morphology | 1.44749356 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.43472154 |
| 46 | MP0002405_respiratory_system_inflammati | 1.42628906 |
| 47 | MP0001849_ear_inflammation | 1.41072624 |
| 48 | MP0000609_abnormal_liver_physiology | 1.38718600 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.38304070 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.38218340 |
| 51 | MP0000343_altered_response_to | 1.36689108 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.36582039 |
| 53 | MP0000604_amyloidosis | 1.35400120 |
| 54 | MP0003091_abnormal_cell_migration | 1.34818669 |
| 55 | MP0002796_impaired_skin_barrier | 1.31951330 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.31741165 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.29790493 |
| 58 | MP0002736_abnormal_nociception_after | 1.29484645 |
| 59 | MP0001851_eye_inflammation | 1.26965190 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.24096379 |
| 61 | MP0003195_calcinosis | 1.23010167 |
| 62 | MP0002398_abnormal_bone_marrow | 1.22527848 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.22293656 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.21607712 |
| 65 | MP0003890_abnormal_embryonic-extraembry | 1.21057575 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.20109367 |
| 67 | MP0004233_abnormal_muscle_weight | 1.19806909 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 1.18514441 |
| 69 | MP0004947_skin_inflammation | 1.15309769 |
| 70 | MP0000566_synostosis | 1.14303641 |
| 71 | MP0001853_heart_inflammation | 1.12399718 |
| 72 | MP0000716_abnormal_immune_system | 1.12170986 |
| 73 | MP0003690_abnormal_glial_cell | 1.11326386 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.10349372 |
| 75 | MP0000858_altered_metastatic_potential | 1.10253931 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.09975105 |
| 77 | MP0010678_abnormal_skin_adnexa | 1.09830415 |
| 78 | MP0003252_abnormal_bile_duct | 1.09645015 |
| 79 | MP0001545_abnormal_hematopoietic_system | 1.09589645 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 1.09589645 |
| 81 | MP0005332_abnormal_amino_acid | 1.09235418 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 1.07063614 |
| 83 | MP0008874_decreased_physiological_sensi | 1.05879153 |
| 84 | MP0003186_abnormal_redox_activity | 1.05784802 |
| 85 | MP0000598_abnormal_liver_morphology | 1.03674981 |
| 86 | MP0001346_abnormal_lacrimal_gland | 1.03029554 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 1.01114126 |
| 88 | MP0005164_abnormal_response_to | 1.00917816 |
| 89 | MP0005671_abnormal_response_to | 1.00705724 |
| 90 | MP0003566_abnormal_cell_adhesion | 1.00304741 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 1.00271808 |
| 92 | MP0004858_abnormal_nervous_system | 0.99559782 |
| 93 | MP0002722_abnormal_immune_system | 0.99209905 |
| 94 | MP0005501_abnormal_skin_physiology | 0.98861318 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.97727842 |
| 96 | MP0002429_abnormal_blood_cell | 0.96486439 |
| 97 | MP0009764_decreased_sensitivity_to | 0.96175131 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95916935 |
| 99 | MP0009672_abnormal_birth_weight | 0.95478578 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 0.95168205 |
| 101 | MP0005000_abnormal_immune_tolerance | 0.94924821 |
| 102 | MP0005375_adipose_tissue_phenotype | 0.93859088 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.92354271 |
| 104 | MP0001730_embryonic_growth_arrest | 0.89814024 |
| 105 | MP0003077_abnormal_cell_cycle | 0.89810061 |
| 106 | MP0003879_abnormal_hair_cell | 0.89022274 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.89006642 |
| 108 | MP0008260_abnormal_autophagy | 0.88362521 |
| 109 | MP0005025_abnormal_response_to | 0.87192958 |
| 110 | MP0005390_skeleton_phenotype | 0.87174214 |
| 111 | MP0002282_abnormal_trachea_morphology | 0.86107357 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.85257953 |
| 113 | MP0002419_abnormal_innate_immunity | 0.84473991 |
| 114 | MP0001666_abnormal_nutrient_absorption | 0.84371587 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84220699 |
| 116 | MP0004808_abnormal_hematopoietic_stem | 0.84081524 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.83951633 |
| 118 | MP0000465_gastrointestinal_hemorrhage | 0.83640596 |
| 119 | MP0000920_abnormal_myelination | 0.83341695 |
| 120 | MP0000249_abnormal_blood_vessel | 0.80706859 |
| 121 | MP0005380_embryogenesis_phenotype | 0.80393502 |
| 122 | MP0001672_abnormal_embryogenesis/_devel | 0.80393502 |
| 123 | MP0005165_increased_susceptibility_to | 0.78946810 |
| 124 | MP0003984_embryonic_growth_retardation | 0.77851059 |
| 125 | MP0002098_abnormal_vibrissa_morphology | 0.77773524 |
| 126 | MP0000750_abnormal_muscle_regeneration | 0.77403523 |
| 127 | MP0002132_abnormal_respiratory_system | 0.77395023 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.77380467 |
| 129 | MP0002971_abnormal_brown_adipose | 0.77170541 |
| 130 | MP0005166_decreased_susceptibility_to | 0.77075647 |
| 131 | MP0002088_abnormal_embryonic_growth/wei | 0.76987045 |
| 132 | MP0005621_abnormal_cell_physiology | 0.76770634 |
| 133 | MP0003448_altered_tumor_morphology | 0.75978645 |
| 134 | MP0009931_abnormal_skin_appearance | 0.75909239 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.74078659 |
| 136 | MP0003191_abnormal_cellular_cholesterol | 0.74027056 |
| 137 | MP0005451_abnormal_body_composition | 0.73833692 |
| 138 | MP0001697_abnormal_embryo_size | 0.73281324 |
| 139 | MP0005310_abnormal_salivary_gland | 0.72536133 |
| 140 | MP0000703_abnormal_thymus_morphology | 0.72348186 |
| 141 | MP0003011_delayed_dark_adaptation | 0.71619386 |
| 142 | MP0009053_abnormal_anal_canal | 0.69142617 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.68965878 |
| 144 | MP0003693_abnormal_embryo_hatching | 0.67322719 |
| 145 | MP0008469_abnormal_protein_level | 0.65594287 |
| 146 | MP0002060_abnormal_skin_morphology | 0.64892462 |
| 147 | MP0005023_abnormal_wound_healing | 0.64432252 |
| 148 | MP0009785_altered_susceptibility_to | 0.64315804 |
| 149 | MP0001216_abnormal_epidermal_layer | 0.64100555 |
| 150 | MP0000377_abnormal_hair_follicle | 0.63982742 |
| 151 | MP0006082_CNS_inflammation | 0.63975084 |
| 152 | MP0009763_increased_sensitivity_to | 0.63589926 |
| 153 | MP0005448_abnormal_energy_balance | 0.62101837 |
| 154 | MP0009643_abnormal_urine_homeostasis | 0.61670703 |
| 155 | MP0005187_abnormal_penis_morphology | 0.61268456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.83987065 |
| 2 | Severe Myopia (HP:0011003) | 4.73537050 |
| 3 | Subacute progressive viral hepatitis (HP:0006572) | 4.45914702 |
| 4 | Toxemia of pregnancy (HP:0100603) | 4.24781114 |
| 5 | Increased nuchal translucency (HP:0010880) | 3.43626208 |
| 6 | Hepatocellular carcinoma (HP:0001402) | 3.29984617 |
| 7 | Spastic diplegia (HP:0001264) | 3.29823802 |
| 8 | Abnormality of the umbilical cord (HP:0010881) | 3.28644988 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.17412161 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.17412161 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.17412161 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.03820900 |
| 13 | Round ear (HP:0100830) | 3.01578144 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.00648819 |
| 15 | Xanthomatosis (HP:0000991) | 2.98778700 |
| 16 | Myocardial infarction (HP:0001658) | 2.98778149 |
| 17 | Myositis (HP:0100614) | 2.94353407 |
| 18 | Micronodular cirrhosis (HP:0001413) | 2.91615999 |
| 19 | Orchitis (HP:0100796) | 2.89388479 |
| 20 | Absent radius (HP:0003974) | 2.88427589 |
| 21 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.82391093 |
| 22 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.82391093 |
| 23 | Single umbilical artery (HP:0001195) | 2.82391093 |
| 24 | Breast carcinoma (HP:0003002) | 2.78682145 |
| 25 | Tetraparesis (HP:0002273) | 2.77832192 |
| 26 | Increased IgE level (HP:0003212) | 2.74022420 |
| 27 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.72906178 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.72721965 |
| 29 | Amyloidosis (HP:0011034) | 2.71788275 |
| 30 | Volvulus (HP:0002580) | 2.71317444 |
| 31 | Hyperacusis (HP:0010780) | 2.70131911 |
| 32 | Poikilocytosis (HP:0004447) | 2.67303830 |
| 33 | Cellulitis (HP:0100658) | 2.64416507 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.64026595 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62592569 |
| 36 | Deep venous thrombosis (HP:0002625) | 2.59979711 |
| 37 | Distal lower limb muscle weakness (HP:0009053) | 2.58658195 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.56778774 |
| 39 | Aplasia involving forearm bones (HP:0009822) | 2.56643771 |
| 40 | Absent forearm bone (HP:0003953) | 2.56643771 |
| 41 | Distal lower limb amyotrophy (HP:0008944) | 2.54901131 |
| 42 | Neurofibrillary tangles (HP:0002185) | 2.52148979 |
| 43 | Cone-rod dystrophy (HP:0000548) | 2.50920250 |
| 44 | Abdominal situs inversus (HP:0003363) | 2.49661071 |
| 45 | Abnormality of abdominal situs (HP:0011620) | 2.49661071 |
| 46 | Loss of speech (HP:0002371) | 2.49384565 |
| 47 | Nasal polyposis (HP:0100582) | 2.48482330 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.48472115 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.47714805 |
| 50 | Purpura (HP:0000979) | 2.47621808 |
| 51 | Nausea (HP:0002018) | 2.45153117 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44119124 |
| 53 | Increased connective tissue (HP:0009025) | 2.42187826 |
| 54 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.39524571 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.39492238 |
| 56 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.39421493 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 2.37916180 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.35754647 |
| 59 | Optic neuritis (HP:0100653) | 2.35754647 |
| 60 | Hyperglycinemia (HP:0002154) | 2.35495998 |
| 61 | Polycythemia (HP:0001901) | 2.34972196 |
| 62 | Absent thumb (HP:0009777) | 2.34750396 |
| 63 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.34291494 |
| 64 | Peripheral hypomyelination (HP:0007182) | 2.33787211 |
| 65 | Abnormal biliary tract physiology (HP:0012439) | 2.32917646 |
| 66 | Bile duct proliferation (HP:0001408) | 2.32917646 |
| 67 | Gingivitis (HP:0000230) | 2.32308271 |
| 68 | Germ cell neoplasia (HP:0100728) | 2.31602421 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.31329204 |
| 70 | Urticaria (HP:0001025) | 2.30028312 |
| 71 | Dysostosis multiplex (HP:0000943) | 2.29615468 |
| 72 | Petechiae (HP:0000967) | 2.29504512 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.29309963 |
| 74 | Muscle fiber splitting (HP:0003555) | 2.29083430 |
| 75 | Epistaxis (HP:0000421) | 2.25326331 |
| 76 | Stomatitis (HP:0010280) | 2.25159775 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 2.24862861 |
| 78 | Overriding aorta (HP:0002623) | 2.24814671 |
| 79 | Meckel diverticulum (HP:0002245) | 2.24040775 |
| 80 | Aqueductal stenosis (HP:0002410) | 2.23424389 |
| 81 | Gingival bleeding (HP:0000225) | 2.22970712 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.21404700 |
| 83 | Obstructive lung disease (HP:0006536) | 2.21404700 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.20865012 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.19840317 |
| 86 | Intrahepatic cholestasis (HP:0001406) | 2.19329175 |
| 87 | Hyperlipoproteinemia (HP:0010980) | 2.18637418 |
| 88 | Abnormality of the common coagulation pathway (HP:0010990) | 2.17492000 |
| 89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.17266265 |
| 90 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.16236920 |
| 91 | Natal tooth (HP:0000695) | 2.16148045 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.15692251 |
| 93 | Abnormality of the carotid arteries (HP:0005344) | 2.15172569 |
| 94 | Impulsivity (HP:0100710) | 2.13785964 |
| 95 | Acanthocytosis (HP:0001927) | 2.13004435 |
| 96 | Premature rupture of membranes (HP:0001788) | 2.12413106 |
| 97 | Hyperglycinuria (HP:0003108) | 2.12390252 |
| 98 | Hypochromic anemia (HP:0001931) | 2.11892748 |
| 99 | Ureteral duplication (HP:0000073) | 2.10677598 |
| 100 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.09527563 |
| 101 | Neuronal loss in central nervous system (HP:0002529) | 2.09227045 |
| 102 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.08860362 |
| 103 | Viral hepatitis (HP:0006562) | 2.08732885 |
| 104 | Insomnia (HP:0100785) | 2.08690217 |
| 105 | Large earlobe (HP:0009748) | 2.08281890 |
| 106 | Abnormality of the ileum (HP:0001549) | 2.07379162 |
| 107 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07001127 |
| 108 | Striae distensae (HP:0001065) | 2.06970975 |
| 109 | Exercise-induced myalgia (HP:0003738) | 2.06406077 |
| 110 | Increased cerebral lipofuscin (HP:0011813) | 2.06326066 |
| 111 | Hyperglycemia (HP:0003074) | 2.05355001 |
| 112 | Thick nail (HP:0001805) | 2.05222905 |
| 113 | Hypoalphalipoproteinemia (HP:0003233) | 2.05127631 |
| 114 | Increased serum ferritin (HP:0003281) | 2.04785250 |
| 115 | Uterine leiomyosarcoma (HP:0002891) | 2.04625484 |
| 116 | Leiomyosarcoma (HP:0100243) | 2.04625484 |
| 117 | Hypobetalipoproteinemia (HP:0003563) | 2.03907971 |
| 118 | Renovascular hypertension (HP:0100817) | 2.03718802 |
| 119 | Elfin facies (HP:0004428) | 2.03204415 |
| 120 | Slow saccadic eye movements (HP:0000514) | 2.01506137 |
| 121 | Gastrointestinal carcinoma (HP:0002672) | 2.00385552 |
| 122 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.00385552 |
| 123 | Complement deficiency (HP:0004431) | 2.00057799 |
| 124 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.99420466 |
| 125 | Obstructive sleep apnea (HP:0002870) | 1.99027256 |
| 126 | Increased variability in muscle fiber diameter (HP:0003557) | 1.98056363 |
| 127 | Vasculitis (HP:0002633) | 1.96629962 |
| 128 | Low anterior hairline (HP:0000294) | 1.95782499 |
| 129 | Hypolipoproteinemia (HP:0010981) | 1.95655304 |
| 130 | Abnormality of nail color (HP:0100643) | 1.95614537 |
| 131 | Reticulocytosis (HP:0001923) | 1.94542343 |
| 132 | Shallow orbits (HP:0000586) | 1.94398802 |
| 133 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94308827 |
| 134 | Abnormality of chromosome stability (HP:0003220) | 1.93570274 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 1.93416284 |
| 136 | Submucous cleft hard palate (HP:0000176) | 1.93052873 |
| 137 | Pustule (HP:0200039) | 1.92547038 |
| 138 | Decreased motor nerve conduction velocity (HP:0003431) | 1.91813578 |
| 139 | Asymmetric septal hypertrophy (HP:0001670) | 1.91316476 |
| 140 | Supranuclear gaze palsy (HP:0000605) | 1.91132132 |
| 141 | Abnormal platelet volume (HP:0011876) | 1.90802493 |
| 142 | Keratoconjunctivitis sicca (HP:0001097) | 1.87938904 |
| 143 | Facial hemangioma (HP:0000329) | 1.87920423 |
| 144 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87252605 |
| 145 | Osteomyelitis (HP:0002754) | 1.87137265 |
| 146 | Peritonitis (HP:0002586) | 1.85269391 |
| 147 | Hypochromic microcytic anemia (HP:0004840) | 1.85171455 |
| 148 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.84758135 |
| 149 | Fatigue (HP:0012378) | 1.84127896 |
| 150 | Polygenic inheritance (HP:0010982) | 1.83624936 |
| 151 | Chest pain (HP:0100749) | 1.83549790 |
| 152 | Recurrent skin infections (HP:0001581) | 1.83395879 |
| 153 | Difficulty climbing stairs (HP:0003551) | 1.83317263 |
| 154 | Neoplasm of the liver (HP:0002896) | 1.83200354 |
| 155 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81980015 |
| 156 | Axonal loss (HP:0003447) | 1.81004661 |
| 157 | Abnormality of iron homeostasis (HP:0011031) | 1.80999793 |
| 158 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80246335 |
| 159 | Hypertriglyceridemia (HP:0002155) | 1.79492057 |
| 160 | Prominent nose (HP:0000448) | 1.78293932 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77861540 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77861540 |
| 163 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77861540 |
| 164 | Meningitis (HP:0001287) | 1.77718304 |
| 165 | Proximal placement of thumb (HP:0009623) | 1.77122403 |
| 166 | Rapidly progressive (HP:0003678) | 1.76836992 |
| 167 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76530505 |
| 168 | Episodic fever (HP:0001954) | 1.76260626 |
| 169 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76247949 |
| 170 | Abnormality of glycine metabolism (HP:0010895) | 1.76247949 |
| 171 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75841465 |
| 172 | Microcytic anemia (HP:0001935) | 1.75576259 |
| 173 | Bladder carcinoma (HP:0002862) | 1.74690062 |
| 174 | Diminished motivation (HP:0000745) | 1.74149213 |
| 175 | Ragged-red muscle fibers (HP:0003200) | 1.73803091 |
| 176 | Lower limb amyotrophy (HP:0007210) | 1.73089773 |
| 177 | Apathy (HP:0000741) | 1.72687707 |
| 178 | Foot dorsiflexor weakness (HP:0009027) | 1.71032401 |
| 179 | Onion bulb formation (HP:0003383) | 1.70576405 |
| 180 | Hepatosplenomegaly (HP:0001433) | 1.70487675 |
| 181 | Achilles tendon contracture (HP:0001771) | 1.69770883 |
| 182 | Abnormal platelet function (HP:0011869) | 1.68197131 |
| 183 | Impaired platelet aggregation (HP:0003540) | 1.68197131 |
| 184 | Gastrointestinal inflammation (HP:0004386) | 1.67821977 |
| 185 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.67555425 |
| 186 | Mucopolysacchariduria (HP:0008155) | 1.67555425 |
| 187 | Cholelithiasis (HP:0001081) | 1.66464990 |
| 188 | Abnormal blistering of the skin (HP:0008066) | 1.65941304 |
| 189 | Osteolytic defects of the hand bones (HP:0009699) | 1.65130577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 5.95946891 |
| 2 | STK38L | 4.69539616 |
| 3 | PRPF4B | 3.74833371 |
| 4 | NEK2 | 3.31745196 |
| 5 | PAK4 | 2.84258537 |
| 6 | RIPK4 | 2.62983455 |
| 7 | PTK6 | 2.58765088 |
| 8 | MAP2K3 | 2.52546188 |
| 9 | BCKDK | 2.51628197 |
| 10 | NTRK2 | 2.43933538 |
| 11 | IRAK3 | 2.29381402 |
| 12 | TAOK2 | 2.23186414 |
| 13 | CDK6 | 2.20672988 |
| 14 | ERN1 | 2.19574658 |
| 15 | MAP3K11 | 2.17239766 |
| 16 | TAOK1 | 2.15525582 |
| 17 | STK38 | 2.04812954 |
| 18 | TRIB3 | 2.03973064 |
| 19 | SRPK1 | 1.94488712 |
| 20 | EPHB1 | 1.87361616 |
| 21 | TBK1 | 1.76770588 |
| 22 | TTK | 1.74190157 |
| 23 | FER | 1.67320061 |
| 24 | RPS6KA4 | 1.64309732 |
| 25 | PDK4 | 1.61226723 |
| 26 | PDK3 | 1.61226723 |
| 27 | IRAK4 | 1.57016992 |
| 28 | STK3 | 1.50866677 |
| 29 | BLK | 1.49136820 |
| 30 | CSK | 1.46877316 |
| 31 | EIF2AK1 | 1.40289119 |
| 32 | ARAF | 1.36309592 |
| 33 | MAP3K13 | 1.35409673 |
| 34 | CHUK | 1.31505388 |
| 35 | MELK | 1.30473414 |
| 36 | STK10 | 1.30309378 |
| 37 | TYK2 | 1.30274279 |
| 38 | MARK2 | 1.29940165 |
| 39 | MAP3K10 | 1.29001579 |
| 40 | SIK1 | 1.28991604 |
| 41 | SIK3 | 1.26703346 |
| 42 | ERBB2 | 1.26291118 |
| 43 | GRK6 | 1.24404751 |
| 44 | CSNK1G3 | 1.21946069 |
| 45 | LATS1 | 1.20376101 |
| 46 | FGFR4 | 1.18907026 |
| 47 | CSNK1A1L | 1.18592348 |
| 48 | MAP4K1 | 1.10627751 |
| 49 | MAP3K6 | 1.08448739 |
| 50 | FES | 1.07255081 |
| 51 | BUB1 | 1.06841669 |
| 52 | PRKD2 | 1.06663638 |
| 53 | FGR | 1.03945815 |
| 54 | TNK2 | 1.02546870 |
| 55 | DYRK1B | 1.02251155 |
| 56 | SIK2 | 0.99914950 |
| 57 | HCK | 0.97602217 |
| 58 | NEK9 | 0.97408673 |
| 59 | BMX | 0.96782781 |
| 60 | PLK4 | 0.96078281 |
| 61 | PKN2 | 0.94514559 |
| 62 | TESK1 | 0.94294066 |
| 63 | MOS | 0.93332819 |
| 64 | SMG1 | 0.93234633 |
| 65 | IRAK2 | 0.92317670 |
| 66 | JAK2 | 0.89556901 |
| 67 | CSNK1G2 | 0.89218346 |
| 68 | JAK1 | 0.88672617 |
| 69 | TAOK3 | 0.87486724 |
| 70 | PDK2 | 0.87174666 |
| 71 | SGK3 | 0.87139137 |
| 72 | ICK | 0.85379137 |
| 73 | CAMK1D | 0.84013442 |
| 74 | CSNK1G1 | 0.83709589 |
| 75 | CDK12 | 0.83466461 |
| 76 | MAPK12 | 0.80812369 |
| 77 | PDPK1 | 0.79952435 |
| 78 | TTN | 0.79309717 |
| 79 | LRRK2 | 0.77398424 |
| 80 | CDC42BPA | 0.76444178 |
| 81 | BRAF | 0.75928261 |
| 82 | MATK | 0.74333050 |
| 83 | KSR1 | 0.73970823 |
| 84 | ACVR1B | 0.73959776 |
| 85 | IKBKE | 0.73744716 |
| 86 | AKT2 | 0.73254141 |
| 87 | WNK1 | 0.71723520 |
| 88 | MST1R | 0.71211845 |
| 89 | BTK | 0.70772979 |
| 90 | SYK | 0.69675357 |
| 91 | MAPKAPK3 | 0.69633594 |
| 92 | PIK3CG | 0.67194194 |
| 93 | EPHA3 | 0.66604418 |
| 94 | PIM1 | 0.66414924 |
| 95 | TESK2 | 0.66087115 |
| 96 | BRSK2 | 0.64940573 |
| 97 | RPS6KA2 | 0.64771560 |
| 98 | MAP3K2 | 0.64499870 |
| 99 | DYRK3 | 0.63732277 |
| 100 | DDR2 | 0.63686668 |
| 101 | PBK | 0.62910590 |
| 102 | MAP3K3 | 0.62657743 |
| 103 | MAPK7 | 0.60817607 |
| 104 | RPS6KL1 | 0.59909628 |
| 105 | RPS6KC1 | 0.59909628 |
| 106 | MARK3 | 0.59306589 |
| 107 | MAP3K5 | 0.59254859 |
| 108 | CAMK1G | 0.59204103 |
| 109 | HIPK2 | 0.58678960 |
| 110 | PDGFRA | 0.57429110 |
| 111 | PDK1 | 0.57408896 |
| 112 | IKBKB | 0.56319625 |
| 113 | PLK1 | 0.55518821 |
| 114 | JAK3 | 0.54938265 |
| 115 | WEE1 | 0.54508447 |
| 116 | PDGFRB | 0.53944155 |
| 117 | MTOR | 0.53680844 |
| 118 | AURKB | 0.53608204 |
| 119 | ABL2 | 0.53185031 |
| 120 | MAP3K8 | 0.53055616 |
| 121 | EPHA2 | 0.52765226 |
| 122 | ERBB4 | 0.52593200 |
| 123 | RAF1 | 0.52386203 |
| 124 | PRKAA2 | 0.52184862 |
| 125 | CAMKK1 | 0.51033513 |
| 126 | MAP2K4 | 0.48931454 |
| 127 | IRAK1 | 0.48324950 |
| 128 | CSF1R | 0.48319244 |
| 129 | STK4 | 0.47037370 |
| 130 | RET | 0.46925926 |
| 131 | KSR2 | 0.46459547 |
| 132 | STK24 | 0.46286544 |
| 133 | RIPK1 | 0.46284631 |
| 134 | YES1 | 0.46085767 |
| 135 | SGK2 | 0.45884521 |
| 136 | SGK223 | 0.44963272 |
| 137 | SGK494 | 0.44963272 |
| 138 | PIM2 | 0.43583059 |
| 139 | LATS2 | 0.43054217 |
| 140 | FYN | 0.42637825 |
| 141 | LYN | 0.41900132 |
| 142 | TGFBR2 | 0.41808054 |
| 143 | PRKAA1 | 0.41559929 |
| 144 | GSK3A | 0.41137068 |
| 145 | PRKD1 | 0.40703557 |
| 146 | MAPK11 | 0.40203230 |
| 147 | EGFR | 0.37748854 |
| 148 | ATM | 0.36860176 |
| 149 | BRSK1 | 0.36717064 |
| 150 | TLK1 | 0.36664937 |
| 151 | ZAP70 | 0.35609139 |
| 152 | PTK2 | 0.34925573 |
| 153 | ATR | 0.32076442 |
| 154 | CDK7 | 0.31695496 |
| 155 | KDR | 0.31085236 |
| 156 | MAP3K14 | 0.29494841 |
| 157 | MAP3K1 | 0.29127905 |
| 158 | STK11 | 0.28918619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.37925720 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.60871807 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.20513839 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08035402 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02173309 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01105484 |
| 7 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.95273718 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93805440 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.93547546 |
| 10 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.82349108 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81188868 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.78331764 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76799870 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76069400 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69550216 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65810391 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64085409 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62909580 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61019421 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57393140 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56765793 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53418714 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48588093 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.45601902 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44987533 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.44415334 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.41193593 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.38185673 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.36908988 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.35863752 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.34501109 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31843333 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30484854 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.27803434 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27640172 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27323557 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25032195 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22458577 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.22126485 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21255246 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19487738 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19023151 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.18759349 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.16748942 |
| 45 | Endocytosis_Homo sapiens_hsa04144 | 1.16419185 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15976338 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14788469 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.14068191 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13915091 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 1.13730004 |
| 51 | Measles_Homo sapiens_hsa05162 | 1.12587169 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.12148113 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11719838 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11287724 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09777685 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09703033 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08316267 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07968365 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 1.07923102 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06309631 |
| 61 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06104205 |
| 62 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.05736249 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04931298 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.04647124 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03757500 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01310771 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 1.00961737 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00725699 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.98316854 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96325367 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93469040 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91156798 |
| 73 | Malaria_Homo sapiens_hsa05144 | 0.90350743 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.89744536 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87937228 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87072943 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87012222 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86447086 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86101052 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85607194 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.84561603 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82663727 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82340473 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82302110 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82105225 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81480481 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80638568 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79413033 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78646019 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78491324 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78386510 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77645205 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76448349 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76282071 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.75966491 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75841364 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75740345 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75177977 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74734159 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74634901 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73988914 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73584682 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73191968 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71464967 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70500236 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69938794 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69909864 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69814937 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68873065 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.68657165 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68291256 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68138898 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67719805 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.67536022 |
| 115 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67529905 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66159375 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65508775 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65085483 |
| 119 | Base excision repair_Homo sapiens_hsa03410 | 0.64580660 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64482046 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63447956 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63328496 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63196962 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63171833 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62799880 |
| 126 | Focal adhesion_Homo sapiens_hsa04510 | 0.62697755 |
| 127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62420659 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62367277 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.61786672 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61561516 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61396068 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61114346 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60037957 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59893460 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58781938 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57980012 |
| 137 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57538314 |
| 138 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57340345 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57253546 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56258718 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | 0.55542514 |
| 142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54562057 |
| 143 | Bile secretion_Homo sapiens_hsa04976 | 0.53993389 |
| 144 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52849403 |
| 145 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52809158 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.52219592 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51298184 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51190970 |
| 149 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49077842 |
| 150 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48634745 |
| 151 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48484996 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.48391082 |
| 153 | Prostate cancer_Homo sapiens_hsa05215 | 0.47230393 |
| 154 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46950924 |
| 155 | Adherens junction_Homo sapiens_hsa04520 | 0.46557365 |
| 156 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46013952 |
| 157 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45814813 |
| 158 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45636444 |
| 159 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45131734 |
| 160 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44487160 |
| 161 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44398970 |

